Further to the announcement by Psyence Group Inc. (Psyence Group) of the closing (Closing) of the business combination of its subsidiary, Psyence Biomedical Ltd. (PBM) with Newcourt Acquisition Corp. (Newcourt) (BusinessCombination or Spin-Out). Dr. Neil Maresky has assumed the role of CEO of PBM to oversee the Psyence Biomed business and has resigned as CEO of Psyence Group.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.329 USD | -7.53% |
|
-11.44% | -96.44% |
1st Jan change | Capi. | |
---|---|---|
-96.44% | 4.27M | |
+56.86% | 823B | |
+43.90% | 641B | |
-6.57% | 352B | |
+17.32% | 324B | |
+9.94% | 301B | |
+16.08% | 241B | |
+2.29% | 223B | |
+13.96% | 218B | |
+7.98% | 167B |
- Stock Market
- Equities
- PBM Stock
- News Psyence Biomedical Ltd.
- Psyence Biomedical Ltd. Appoints Neil Maresky as CEO